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Reactive oxygen species are not only harmful agents that cause oxidative damage in pathologies, they also
have important roles as regulatory agents in a range of biological phenomena. The relatively recent develop-
ment of this more nuanced view presents a challenge to the biomedical research community on how best to
assess the significance of reactive oxygen species and oxidative damage in biological systems. Consider-
able progress is being made in addressing these issues, and here we survey some recent developments
for those contemplating research in this area.Introduction
Reactive oxygen species (ROS), oxidative stress, and oxidative
damage are increasingly assigned important roles in biomedical
science as deleterious factors in pathologies and aging. There is
also the growing recognition that many ROS are in addition
important mediators in a range of biological processes such as
signaling. However, this greater interest in ROS raises the con-
cern that too often a certain biological phenomenon is ascribed
to ROS or oxidative damage based on inadequate rationales,
technical approaches, or understanding of what is chemically
plausible. This tendency is surprising as there is considerable
knowledge available on the detailed chemistry of individual
ROS and the oxidative reactions that can occur within biological
systems. However, this knowledge is often seen as technically
specialized or inaccessible to those in other areas of biomedical
science whose research, perhaps unexpectedly, leads them to
suspect a role for ROS in their work. Consequently, there are
many examples of otherwise well-conducted studies of consid-
erable general interest that contain superficial or flawed conclu-
sions about the involvement of ROS in the process investigated.
A corollary is that technical approaches to measuring and block-
ing the actions of ROS and oxidative damage within biological
systems are often difficult to interpret and prone to artifact.Consequently, results need tobeassessedcautiouslywithaclear
understanding of what the methods used do or do not measure.
The multiple facets of this problem pose a challenge to those
studying the chemical and biophysical sides of ROS to explain
better what is possible andwhat is not, and to develop and publi-
cize more effective tools for investigating the impact of different
ROS, particularly in vivo.
To discuss current understanding of ROS in biology, and to
explore how challenges in the field could be addressed, a group
of leading researchers with biological and chemical perspectives
on ROS was brought together for an interdisciplinary confer-
ence, ‘‘The Chemistry and Biology of Reactive Oxygen Species,’’
funded by the Wenner-Gren Foundations and held in Stockholm
from September 8–11, 2010. A number of common threads
emerged from the meeting that are of general interest to the
biomedical research community.
Making the Chemistry Explicit
A major recurrent theme from those working on the chemistry of
ROS and oxidative damage was the importance of under-
standing the nature of the particular ROS under consideration
in a biological context (Winterbourn, 2008). In other words,
‘‘ROS’’ is often used imprecisely in the biomedical literatureCell Metabolism 13, April 6, 2011 ª2011 Elsevier Inc. 361
Box 1. A Checklist for Assessing a Role for ROS in Biological
Processes
d What is the specific ROS responsible?
d Is the proposed reaction chemically plausible?
d Is the ROS or antioxidant present at the appropriate location at
a sufficient concentration to carry out the proposed reaction?
d Does altering the amount of the particular ROS or type of oxida-
tive modification thought responsible impact on the pathology or
the redox signal?
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course, there are many situations in which the use of ROS as
a generic description is appropriate. However, in some cases it
can be unhelpful and misleading because biologically important
ROS encompass a diverse range of species, including super-
oxide, hydrogen peroxide, nitric oxide, peroxynitrite, hypochlo-
rous acid, singlet oxygen, and the hydroxyl radical. Each of these
molecules is a distinct chemical entity with its own reaction
preferences, kinetics, rate and site of production, and degrada-
tion and diffusion characteristics in biological systems. Conse-
quently the biological impacts of ‘‘ROS’’ depend critically on
the particular molecule(s) involved and on the microenvironment
and physiological or pathological context in which it is being
generated. To group all ROS together as a single entity is
imprecise and can lead to vague and untestable hypotheses.
Therefore, wherever possible, the particular species thought
to be responsible for the phenomenon under study should be
specified.
A similar error is a tendency to treat all antioxidants as if they
were alike, when in fact each has its own chemical properties
and selective reactivity with particular types of ROS, as well
as distinctive distribution, metabolism, recycling, and other
potential effects within a biological context. For example,
vitamin E and vitamin C interact with different ROS in vivo in
quite different ways because of their very different chemistry
and in addition because the former is present within lipids while
the latter is found in the aqueous phase. Furthermore, neither
they nor most other small molecule antioxidants react with
hydrogen peroxide. Enzymatic antioxidants such as superoxide
dismutase, glutathione peroxidase, catalase, and peroxiredox-
ins are selective for particular ROS, and some, such as super-
oxide dismutase, act by converting one type of ROS (super-
oxide) into another (hydrogen peroxide) and by preventing
formation of a further potent oxidant (peroxynitrite). Thus an
antioxidant may block the activity of one type of ROS but leave
another form unscathed. Furthermore, localization and catalytic
activities of antioxidant enzymes may be regulated via post-
translational modification (such as acetylation, phosphorylation,
and cysteine oxidation) and interaction with other proteins. For
example, the mechanisms by which peroxiredoxins remove
peroxides and peroxynitrite require disulfide reduction by thio-
redoxin. Moreover, mammalian thioredoxins are themselves
regulated by reversible inactivation via two-disulfide formation
or nitrosylation involving structural cysteine residues (Hashemy
and Holmgren, 2008). Such regulation may provide a means of
generating favorable gradients of hydrogen peroxide around the
appropriate location at the right time for signaling in response
to stimulation of cell surface receptors (Woo et al., 2010). In
addition, aquaporins and related channels may provide a mech-
anism to regulate local hydrogen peroxide fluxes (Miller et al.,
2010).
In summary, it would be helpful if researchers specified the
particular ROS and the reactions thought to be responsible for
given biological effects and, wherever possible and appropriate,
avoided vague usage of generic terms like ROS and antioxidant.
Likewise, researchers should show that an antioxidant actually
reacts with the particular ROS under discussion and can, at least
in principle, lower the concentration of that ROS sufficiently
in vivo to explain its action.362 Cell Metabolism 13, April 6, 2011 ª2011 Elsevier Inc.Determining whether a Particular ROS Plays a Role
in a Biological Phenomenon
To overcome the shortcomings outlined above, we recommend
that researchers (and reviewers) routinely go through a checklist
of a few simple, common sense principles before assigning
a proposed redox mode of action of ROS and antioxidants
(Box 1). This has been suggested before (Gutteridge and Halli-
well, 2010; Halliwell and Gutteridge, 2007), and is, if you like,
equivalent to ‘‘Koch’s postulates’’ for ROS and oxidative
damage. It will not be possible to satisfy all these criteria in every
case, for example the direct measurements of particular ROS
suggested in Box 1 may not be feasible in vivo. Even so, these
criteria are still useful to assess whether the conclusion reached
or the hypothesis proposed is in principle plausible. Without
such a heuristic approach it is difficult to determine whether
a change in concentration of a particular ROS or the effect of a
certain antioxidant is indicative of a role for a specific ROS in
a pathology or redox signal. Alternative interpretations should
be considered; for example, oxidative damage can accumulate
as a secondary consequence of other events (e.g., changes in
repair rates, since oxidative damage and its repair occur contin-
ually in aerobes), and many of the molecules used as antioxi-
dants have other pharmacological effects.
The above considerations can help identify shortcomings in
ROS-related investigations, some of which occur regularly in
the biomedical literature. For example, there is a tendency to
automatically link mitochondrial dysfunction with increased
production of superoxide or hydrogen peroxide. However, the
experimental support for this link is weak as there are many
examples of mouse models with severe respiratory chain
dysfunction that do not have any major increase in hydrogen
peroxide or superoxide production or oxidative damage (Wang
et al., 2001; Trifunovic et al., 2005; Kujoth et al., 2005). In addi-
tion, studies of isolated mitochondria suggest that the link
between hydrogen peroxide or superoxide production and mito-
chondrial dysfunction is complex (Murphy, 2009). Finally, it
should be mentioned that the role for oxidative damage in aging
as originally proposed (Harman, 1956) is still actively debated.
For example, experimental studies imply that moderately in-
creased mitochondrial oxidative damage is well tolerated and
does not affect life span in themouse (Jang and Remmen, 2009).
Another area that can be problematic is interpreting the effects
of antioxidants. Consider the use of superoxide dismutase (SOD)
mimetics to test whether superoxide is responsible for a partic-
ular effect in a biological system. The rate constants for SOD
mimetics are generally 100-fold lower than that of enzymatic
SOD itself, which is often present at concentrations greater
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SOD mimetic increases tissue SOD activity significantly over
endogenous levels (e.g., Keaney et al., 2004) before concluding
that its biological activity is due to depleting superoxide. Another
consideration is that it is most unlikely that the biological mode of
action of any antioxidant is through hydroxyl radical scavenging
(Halliwell and Whiteman, 2004). This is because the hydroxyl
radical reacts at a diffusion limited rate with most biological
molecules, so no exogenous molecule could achieve the
concentration required to compete with this process (Halliwell
and Whiteman, 2004). A further point is the widespread use of
N-acetylcysteine (NAC) as a generic antioxidant in biological
situations (Atkuri et al., 2007). As a membrane-permeant
cysteine precursor, many of its effects may be due to increasing
cellular thiol (e.g., GSH) levels, but often this is not examined and
many other effects may contribute (Zafarullah et al., 2003). For
example, an increase in the free thiol content within the cell, or
perhaps just in the cell culture medium (Xu and Thornalley,
2001; Mi, et al., 2010), may explain many of the observed effects.
However, direct scavenging of hydrogen peroxide by NAC is
unlikely as the reaction between these species is very slow. In
addition, NAC might exert its effect by causing structural
changes in cell-surface proteins (Hayakawa et al., 2003),
because the extracellular domain of many cell surface receptors
contains disulfide bridges, which can be reduced by NAC (Hay-
akawa et al., 2003). Thus, the action of NAC may be more as
a redox modulator, and it should not be described as an antiox-
idant unless there is specific evidence that it is acting in this way.
Similarly, many other compounds such as dietary polyphenolics
act as antioxidants in simple in vitro systems, but it is often
unclear whether the compound is present at a sufficient concen-
tration in vivo to lower the levels of the relevant ROS. Conse-
quently, many ‘‘antioxidant’’ effects in vivo may be due to
some other pharmacological interaction distinct from a decrease
in a particular ROS. Therefore, proposed lowering effects of
specified ROS by a particular antioxidant should, if possible,
be confirmed by measuring levels of the particular ROS suppos-
edly scavenged by the compound.
Measuring ROS Production and Oxidative Damage
Amajor theme that emerged from the meeting is the urgent need
for better approaches to measuring the different types of ROS
and forms of oxidative damage that occur in biological systems,
particularly in vivo. It is important to distinguish between the
measurement of particular ROS themselves and the assessment
of the damage that these ROS cause. Biomarkers of oxidative
damage such as protein carbonyls, lipid peroxidation products,
or breakdown products of damaged DNA are often used, partic-
ularly in vivo, to infer production of ROS such as the hydroxyl
radical. However, the link between the accumulation of a marker
for oxidative damage and production of a particular ROS is
indirect, because a change in clearance can dramatically alter
the level of the marker with no change in production of a
given ROS. For example, protein carbonylation is elevated by
mistranslation of proteins, even when the levels of ROS are
unaltered, due to an increased susceptibility of misfolded
proteins to oxidative attack (Dukan et al., 2000). Conversely, as
hydrogen peroxide can act as a redox signal without causing
significant oxidative damage, its levels can change in biologicallysignificant ways without necessarily resulting in oxidative
damage accumulation.
Validation of better biomarkers for the assessment of oxidative
damage in vivo, particularly in human samples, should be
a priority. A great deal of research effort is directed toward linking
the detailed chemistry of oxidative damage to protein, lipid, and
DNA with the production of measurable biomarkers (Jacobson
et al., 2010; Portero-Otı´n et al., 2004). The current best available
biomarker for lipid peroxidation seems to be isoprostanes.
However, work (e.g., Xue et al., 2009) on the detailed measure-
ment of oxidative damage to proteins and nucleic acids by
mass spectrometry suggests that many more biomarkers are
likely to be developed and our understanding of the link between
the levels of biomarkers such as protein carbonyls, 8-hydroxy-
deoxyguanosine, F2-isoprostanes, and reactive aldehydes that
can be measured in biological fluids, and the reactions that
lead to their accumulation may assist this. A corollary of this is
that it is unlikely that a single biomarker will ever give a complete
picture of oxidative damage in vivo as different types of damage
to lipids, the proteome or the genome will lead to distinct
patterns of accumulation of biomarkers, while interventions
such as antioxidants will also affect the accumulation of
biomarkers differentially. Hence, whatever biomarkers are used
they are not necessarily a simple single marker of overall oxida-
tive damage but will each respond differently to alternative types
of damage and interventions.
Research into new approaches in the technically difficult area
of measuring the levels of specific ROS in biological systems is
gaining momentum. Often these experiments are done with
redox-sensitive probes that are very susceptible to artifactual
side reactions. For example, dichlorodihydrofluorescein
(DCFH) oxidation to the fluorescent dichlorofluorescein (DCF)
is widely employed and is often described as measuring ROS
production. It is frequently inferred that this is synonymous
with hydrogen peroxide production, but all too often evidence
for this link is not made. Furthermore, there are many issues
with respect to the specificity of this assay, as discussed in
more detail elsewhere (Wardman 2007). A major consideration
is that DCFH does not react directly with hydrogen peroxide
but requires a peroxidase or transition metal catalyst. The signal
also depends on the extent of uptake of DCFH, so there are
many ways in which it can vary without any change in hydrogen
peroxide production (Wardman, 2007). In addition, DCFH is
readily photosensitized and can also catalyze the production of
superoxide. Finally, the relationship between the intensity of
DCF fluorescence and the concentration of the ROS under
consideration is often assumed to be linear, in that a doubling
of fluorescence indicates a doubling of the ROS concentration,
however the relationship between DCF fluorescence and partic-
ular ROS levels is often nonlinear (Wang and Joseph, 1999),
perhaps due to changes in levels of transitionmetals that convert
more H2O2 into hydroxyl radical or to the artifactual generation of
superoxide and hydrogen peroxide by this probe (Halliwell and
Gutteridge, 2007; Wardman 2007). Caveats also apply to the
interpretation of results obtained with other probes such as
hydroethidine, its mitochondria-targeted derivative MitoSOX,
and Amplex Red which also have side reactions and a range of
associated artifacts (Zhao et al., 2005; Selivanov et al., 2008).
There is no simple solution to the difficulty of measuring aCell Metabolism 13, April 6, 2011 ª2011 Elsevier Inc. 363
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cautious use of probes and an effort to corroborate themeasure-
ment using orthogonal techniques is needed.
In developing the next generation of probes for specific ROS,
a few simple principles must be observed: the location of the
probe molecule within the cell or organism must be understood,
the chemistry and rates of the reaction of the probe with different
types of ROS must be clear so that the particular ROS respon-
sible for the response can be established, and the subsequent
metabolism or decomposition of the oxidized probe must be
understood (Zhao et al., 2005; Winterbourn, 2008). In doing so,
the parallel assessment of the probes to correlate the end points
of their reactions with the ROS of interest to the changes in
signals such as fluorescence and an assessment of the sensi-
tivity of the probe to particular ROS, as has been done to char-
acterize the superoxide-selective hydroethidine probe (Zhao
et al., 2005; Zielonka et al., 2008), will be essential. Using these
approaches to measure particular ROS in simple systems such
as isolated enzymes or mitochondria helps us to better under-
stand the basic processes involved. However, these findings
should be extrapolated to the in vivo situation with great caution,
if at all, because often the factors determining the production of
a particular ROS in vivo are quite different from those in vitro
(Murphy, 2009). Therefore, there is a great need for methods to
measure ROS in vivo, and considerable progress has been
made with probe development for live imaging, although some
of this is still in the chemical literature and has yet to be widely
adopted by the biomedical community.
One increasingly important approach is through the engi-
neering of green fluorescent protein (GFP) and its variants to
produce redox-sensitive fluorescent probes, such as roGFP
(Hanson et al., 2004) and HyPER (Belousov et al., 2006). These
proteins incorporate redox-sensitive cysteines into the b barrel
of GFP (Hanson et al., 2004) or integrate GFP and related deriv-
atives into redox-regulated protein motifs, such as the hydrogen
peroxide sensor from OxyR (Belousov et al., 2006) or the yeast
peroxiredoxin Orp1 (Gutscher et al., 2009). These procedures
generate probes that react selectively with a particular ROS,
such as hydrogen peroxide, and then undergo changes in fluo-
rescence with a high degree of sensitivity. There are a number
of advantages of these fluorescent protein probes: the signal is
reversible, allowing its calibration in the cell thereby permitting
a comparison of basal levels of particular ROS or the status of
particular redox couples among different cell types, or in
response to various stimuli, something that is not possible with
probes such asDCFH (Meyer andDick, 2010). Another important
advantage is that these proteins can be easily modified with
targeting sequences so as to be expressed at particular intracel-
lular locations, such as the mitochondria or endoplasmic retic-
ulum, and thereby report on localized redox changes within the
cell (Enyedi et al., 2010). Finally, using cell-specific promoters,
these sensors can be introduced into the genome to generate
transgenic animals that demonstrate cell- and region-specific
expression of the sensor (Guzman et al., 2010). Such methods
can be readily translated to in vivo models in transgenic animals
expressing these redox-sensitive fluorescent proteins, such as
zebrafish or worms, or in conjunction with two photon confocal
microscopy techniques to probe deeper beneath the surface in
nontransparent animals. These methods can also be combined364 Cell Metabolism 13, April 6, 2011 ª2011 Elsevier Inc.to study the redox changes within organelles in specific cell
types; for example, by using a tyrosine hydroxylase-promoter-
driven mitochondrial roGFP, it was possible to explore how
DJ-1 affects mitochondrial redox state within dopaminergic
neurons (Guzman et al., 2010). Finally, the midpoint potential of
the roGFP sensors can be manipulated by inserting an extra
amino acid between the cysteine residues in the sensor, making
it more difficult to oxidize. This approach has already been
reported to be effective in assessing the redox state of the
endoplasmic reticulum, where the more oxidizing environment
renders the original sensor ineffective because it remains almost
fully oxidized under basal conditions (Meyer and Dick, 2010).
However, as with all probes, there are limitations and caveats
in using this class of protein probe. For example, for some of
them the effect of pH on their sensitivity in different cell compart-
ments can complicate analysis and the dynamic range of their
response is generally lower than that of small molecule fluores-
cent probes (Meyer and Dick, 2010).
An alternative to the use of fluorescent proteins is to improve
the selectivity of small-molecule fluorescent probes. A good
example of this process is the use of the selective reactivity of
alkylboronates with hydrogen peroxide (Miller et al., 2007; Dick-
inson et al., 2011) and their even faster reaction with peroxynitrite
(Sikora et al., 2009; Zielonka, et al., 2010) to generate novel fluo-
rescent products. This enables the construction of probes that
appear to be selective for these species and that avoid many
of the limitations of earlier ROS probes such as DCFH. These
probes can also be coupled to functionalities that direct them
to particular parts of the cell, such as mitochondria, in order to
report on both the nature and location of intracellular production
of particular forms of ROS (Dickinson and Chang, 2008; Robin-
son et al., 2006).
One potential limitation to all optical methods for ROS and
redox measurements is that they will not be applicable to most
animalmodels in vivo and there is the further problemof thequan-
tification of the levels of a particular ROS. Therefore to comple-
ment these approaches, nonoptical methods to detect ROS are
also required. Among those that can be used now to gain some
insight into ROS production in vivo is measurement of changes
in the transcription of genes that are sensitive to the levels of
superoxide or hydrogen peroxide (e.g., Landriscina et al.,
2009). While these approaches provide useful information on
changes in some ROS in vivo, they do not indicate the level of
ROS present in vivo and a number of other approaches have
been used to provide this information. Among these has been
the use of spin traps in vivo that react selectivelywith free radicals
to generate a relatively stable free radical that can then be
detected by electron paramagnetic resonance or by mass spec-
trometry (Reis et al., 2009; Yue Qian et al., 2005). However, this
approach can be limited by its low sensitivity and themetabolism
of the spin adduct. This general approach is being extended by
methods under development that greatly enhance the sensitivity
of detection with the ratiometric analysis of a probe that reacts
withparticularROSand its stable reactionproduct relative to their
deuterated internal standards by liquid chromatography and
tandem mass spectrometry. The first application of this com-
bined the alkylboronate chemistry discussed above with mito-
chondrial targeting to quantify the levels of hydrogen peroxide
within mitochondria inside living fruit flies (Cocheme´ et al. 2011).
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specific ROS probes will replace the widely used, but prob-
lematic, current generation of reagents and facilitate the
measurement of particular ROS selectively in vivo.
Conclusions and Future Perspectives
The difficulty of measuring oxidative damage and the levels of
particular ROS in vivo, together with the uncertainty of interpre-
tation, mean that much is still unknown about the roles of ROS
and oxidative damage in many fundamental biological pro-
cesses. For example, despite extensive investigation, most trials
of antioxidants in humans have proven disappointing (Bjelakovic
et al., 2008). However, without accompanying biomarker and
ROS measurements, most of these studies are inconclusive.
We cannot be certain that the lack of efficacy was due to the
antioxidants failing to affect the oxidative damage involved in
the pathology (Gutteridge and Halliwell, 2010). Alternatively,
the compounds may have lowered or abolished oxidative
damage but still had no impact on outcome, implying that oxida-
tive damage merely correlates with the pathology and is not
causative (Cocheme´ and Murphy, 2010).
Looking forward, this meeting of researchers in the chemistry
and biology of ROS revealed that two significant challengesmust
be met to help progress our understanding of ROS and oxidative
damage in living systems. The first challenge is to transmit to
a wider audience the knowledge we have already assembled
so that it can be used to formulate more precise and testable
hypotheses about the role of specific ROS and antioxidants in
the laboratory and clinic. The second challenge is to develop
better approaches for detecting and quantifying different types
of ROS and markers of a range of forms of oxidative damage
in biological systems, particularly in vivo. There was cautious
optimism among the group that a more rigorous approach would
enable faster progress in the field. Although the results may ulti-
mately show that changes in ROS and oxidative damage in some
situations are merely epiphenomena, possibly (for example)
during aging (Gems and Doonan, 2009), it is also likely that it
will reveal unexpected new roles for ROS at the heart of other
major biological phenomena both as damaging agents and as
important mediators of redox signaling and other cellular
processes.
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